ArticleInternational journal of medical sciences2026
Clinical effects of glucagon-like peptide-1 receptor agonist in type 2 diabetes with low body mass index: findings from large-scale emulated target trials.
Ming-Hsien Tsai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.